Formic acid methanol → 4-[2-(5-Chlorothiophen-2-yl)-ethenesulfonyl]-1-(2-pyrrolo[3 2-c]pyridin-1-ylethyl)-piperazin-2-one
Reaction equation
C(OC([N:11]1[CH2:16][CH2:15][N:14]([CH2:17][CH2:18][N:19]2[C:27]3[CH:26]=[CH:25][N:24]=[CH:23][C:22]=3[CH:21]=[CH:20]2)[C:13](=[O:28])[CH2:12]1)=O)C1C=CC=CC=1.C(O)=O.CO.[Cl:34][C:35]1[S:39][C:38]([CH:40]=[CH:41][S:42](Cl)(=[O:44])=[O:43])=[CH:37][CH:36]=1>[Pd].C(#N)C>[Cl:34][C:35]1[S:39][C:38]([CH:40]=[CH:41][S:42]([N:11]2[CH2:16][CH2:15][N:14]([CH2:17][CH2:18][N:19]3[C:27]4[CH:26]=[CH:25][N:24]=[CH:23][C:22]=4[CH:21]=[CH:20]3)[C:13](=[O:28])[CH2:12]2)(=[O:44])=[O:43])=[CH:37][CH:36]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
4-(Benzyloxycarbonyl)-1-(2-pyrrolo[3,2-c]pyridin-1-ylethyl)-piperazin-2-one (0.028 g, 0.074 mmol), EXAMPLE 98, is treated with 4% HCO2H/MeOH (5 mL) and a catalytic amount of Pd black for 5 minutes. The reaction mixture is filtered washed with methanol and the filtrate is concentrated to a residue. The residue is treated with acetonitrile (3 mL) excess N-methylmorpholine (0.04 mL) and 2-(5-chlorothiophen-2-yl)ethene-sulfonyl chloride (0.018 g, 0.074 mmol), EXAMPLE 3, and processed as usual (EXAMPLE 719). Further chromatographic purification (NH4OH/MeOH/CH2Cl2: 1/4/95) yields the title compound: MS m/z 451, 453 (M+H); 1H NMR (CDCl3, 300 MHz) δ8.93 (bs, 1H), 8.24 (bs, 1H), 7.41 (d, 1H), 7.23 (d, 1H), 7.14 (m, 2H), 6.94 (d, 1H), 6.68 (d. 1H), 6.18 (d, 1H), 4.43 (t, 2H), 3.67 (t, 2H), 2.88 (t, 2H), 2.66 (t, 2H).
Workup
- filtrationThe reaction mixture is filtered
- washwashed with methanol
- concentrationthe filtrate is concentrated to a residue
- customFurther chromatographic purification (NH4OH/MeOH/CH2Cl2: 1/4/95)
Sources & evidence
- ORD record
- ord-41fb93e1b432451d961722e317f76724
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07612075B2
Reaction notes
Loading…